Abstract
PFTK1, also named Cyclin-Dependent Kinase 14 (CDK14), is a member of the cell division cycle 2 (CDC2)-related protein kinase family. It is a serine/threonine-protein kinase involved in the regulation of cell cycle progression and cell proliferation. In this study, we investigated the role of PFTK1 in epithelial ovarian cancer (EOC) development. The expression of PFTK1 was detected by Western blot and immunohistochemistry staining, both of which demonstrated that PFTK1 was overexpressed in EOC tissues and cells. Statistical analysis showed the expression of PFTK1 was associated with multiple clinicopathological factors, including tumor grade, FIGO stage, lymph node metastatis, Ki-67 expression and predicted a poor prognosis of EOC patients. With in vitro studies we found that PFTK1 expression was decreased in serum-starved ovarian cancer cells, and progressively increased after serum-re-feeding. Knocking PFTK1 down by small interfering RNA (siRNA) significantly inhibited ovarian cancer cell proliferation, migration and invasion. Taken together, our study suggested that PFTK1 played an important role in ovarian cancer development.
References
Jan 14, 1998·International Journal of Cancer. Journal International Du Cancer·M MaroneS Mancuso
Mar 27, 2001·Japanese Journal of Cancer Research : Gann·M MiharaD T Wong
Apr 21, 2001·Gene·T Yang, J Y Chen
May 3, 2005·Nature Reviews. Cancer·Honami Naora, Denise J Montell
Jun 16, 2006·Cell Research·Yankun GaoJiangye Chen
May 23, 2007·Proceedings of the National Academy of Sciences of the United States of America·Fang ShuJun Wu
Jun 15, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Etonia Y-T PangNathalie Wong
Oct 25, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S J KimS Noguchi
Feb 13, 2008·Developmental Cell·Arnaud BessonJames M Roberts
Jun 19, 2008·Cancer Research·Chakravarty DimpleRatna K Vadlamudi
Feb 26, 2009·Breast Cancer Research : BCR·Satoshi NakayamaNaoto T Ueno
Jun 16, 2009·FEBS Letters·Mei JiangJiangye Chen
Nov 4, 2009·Nature Cell Biology·Marcos MalumbresDebra J Wolgemuth
Jan 12, 2010·Developmental Cell·Gary DavidsonChristof Niehrs
Jan 27, 2010·Genetics·Dongmei Liu, Russell L Finley
Apr 7, 2010·Cancer Genetics and Cytogenetics·Kazuhiro TsujiToshikazu Yoshikawa
Jul 16, 2010·Trends in Cell Biology·Gary Davidson, Christof Niehrs
Sep 23, 2010·Cancer Research·Erinn B RankinAmato J Giaccia
Feb 16, 2012·British Journal of Cancer·H MiyagakiY Doki
Mar 24, 2012·Journal of Cellular Biochemistry·Yingying WangChun Cheng
Feb 9, 2013·The Journal of Biological Chemistry·Yuchan WangAiguo Shen
Jul 16, 2013·Oncogene·N PanupinthuG B Mills
Dec 18, 2013·Oncogene·C WanA Shen
Mar 13, 2014·Acta Biochimica Et Biophysica Sinica·Shan LiJiangye Chen
Mar 14, 2014·PloS One·Yan XiaHeng-Yu Fan
May 6, 2014·FEBS Letters·Shan LiJiangye Chen
May 16, 2014·Biochemical and Biophysical Research Communications·Tingting SunNathalie Wong
Aug 28, 2014·PloS One·Yinghui ZhouJoerg Heyer
Oct 31, 2014·Journal of Molecular Neuroscience : MN·Hai Jie YangZhi Wei Feng
Dec 20, 2014·World Journal of Translational Medicine·Arpita DesaiVeena N Rao
Citations
Dec 2, 2017·Cancer Science·Yoshimi ImawariKiyotsugu Yoshida
Nov 15, 2018·Journal of Cellular Biochemistry·Jia-Peng LiTong-Cun Zhang
Jun 13, 2019·Oncology Letters·Shuigen ZhongYanlong Liu
Aug 20, 2019·Oncology Letters·Yi-Hang YuanDao-Ming Li
May 8, 2020·Cancer Cell International·Lijuan ZhuZehua Li
Nov 21, 2020·World Neurosurgery·Xiaoling YinZhihua Zhang
Jan 9, 2021·Cancer Management and Research·Minmin WuJiadong Su
Oct 17, 2020·OncoTargets and Therapy·Mei JiangWentao Yue
Dec 10, 2016·Journal of Proteome Research·Ritin SharmaJohn M Koomen
Jan 1, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Qi LiLei Qi
Jul 28, 2016·Oncology Research·Jiankang ZhuMin Zhu
Jul 28, 2016·Oncology Research·Mei-Han LiuEn-Qi Chen
Apr 20, 2021·The Journal of Gene Medicine·Yunpeng SunHuanhuan Wu